Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Integer Holdings's Business Segments

Integer Holdings's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
3
Per the company's own filing, this quarter
Largest Segment
Cardio and Vascular
Total Revenue
$ 464
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/ITGR/segments
https://api.csimarket.com/api/v1/companies/ITGR/geographic
https://api.csimarket.com/api/v1/companies/ITGR/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - FY

0%largest
  • Cardio and Vascular0%
  • Cardiac Rhythm Management & Neuromodulation73.7%
  • Other Markets4.2%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Cardio and VascularFY$ 542--
Cardiac Rhythm Management & NeuromodulationFY$ 34273.7%-
Other MarketsFY$ 204.2%-

Revenue by Product & Service Category - FY

60%largest
  • Cardio and Vascular60.4%
  • Cardiac Rhythm Management & Neuromodulation37.4%
  • Other Markets2.2%

Revenue by Product & Service Category - FY

CategoryPeriodRevenue
(Millions)
% of Total
Cardio and VascularFY$ 28060.4%
Cardiac Rhythm Management & NeuromodulationFY$ 17437.4%
Other MarketsFY$ 102.2%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

Annual Results

Revenue Share by Reportable Segment - FY

0%largest
  • Cardio and Vascular0%
  • Cardiac Rhythm Management & Neuromodulation73.7%
  • Other Markets4.2%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Cardio and VascularFY$ 542--
Cardiac Rhythm Management & NeuromodulationFY$ 34273.7%-
Other MarketsFY$ 204.2%-

Description of Integer Holdings

Integer Holdings Corporation is a medical technology company that focuses on the development, manufacture, and distribution of medical devices and components. The company was founded in 1974 and is headquartered in Plano, Texas. The company operates through two segments: Medical and Non-Medical.

The Medical segment designs, develops, and manufactures medical devices and components for a wide range of markets, including cardio and vascular, neurovascular, advanced surgical, and orthopedics. These medical devices include implants, instruments, and other medical components for a variety of clinical applications.

The Non-Medical segment provides precision components for non-medical applications, including aerospace and defense, industrial, and commercial markets. This segment offers a range of products such as connectors, springs, and subassemblies.

The company has a global presence with manufacturing and design facilities in areas such as the United States, Europe, and Asia. It is actively involved in research and development efforts to deliver innovative and quality products to its clients.

Due to its extensive product portfolio, investment in research and development, and global presence, Integer Holdings Corporation is a leader in the medical technology industry. The company has a diverse customer base including medical device OEMs, contract manufacturers, and other non-medical technology companies. It serves these clients with a mix of standard and custom solutions to meet their specific needs.

Integer Holdings Corporation has a commitment to sustainability and social responsibility. The company strives to reduce its environmental impact, improve the health and safety of its employees, and give back to the communities where it operates. It has programs in place to promote these values and continually looks for opportunities for improvement.

Overall, Integer Holdings Corporation is a reputable and globally recognized company that is dedicated to providing innovative medical technology solutions that make a positive impact on people's lives.
Integer Holdings Corporation operates with a strategic focus on two key segments: Medical and Non-Medical. Each segment encompasses a diverse range of products and services tailored to meet the unique needs of their respective markets.

Segments:

1. Medical Segment
The Medical Segment of Integer Holdings Corporation is dedicated to the design, development, and manufacturing of advanced products and services aimed at addressing a variety of medical needs. This segment serves several critical areas in healthcare:

- Cardiology: This division specializes in products that facilitate the diagnosis and treatment of cardiovascular diseases. The product line includes:
- Diagnostic Catheters: Used for the assessment of heart conditions and for procedures that require access to the cardiovascular system.
- Electrophysiology Catheters: Utilized in the mapping and treatment of arrhythmias, these catheters are essential tools for electrophysiology studies and ablation procedures.
- Other Cardiac Devices: This may include implantable devices and systems intended for long-term cardiac monitoring and therapy.

- Neuromodulation: Recognizing the increasing prevalence of neurological disorders, this division offers products that cater to the treatment of conditions such as:
- Spinal Cord Stimulation Systems: These devices are designed to relieve chronic pain through electrical stimulation of the spinal cord.
- Deep Brain Stimulation Systems: Used primarily in the treatment of movement disorders, these systems deliver targeted electrical impulses to specific brain regions.
- Neurostimulation Devices: Additional devices aimed at treating epilepsy and other neurological conditions, providing therapeutic benefits through neuromodulation techniques.

- Vascular and Structural Heart: This division focuses on innovative solutions for vascular interventions and structural heart repairs, thereby improving patient outcomes. Product offerings include:
- Catheter-Based Delivery Systems: Devices specifically designed for the precise delivery of therapies within the vascular system.
- Occlusion Devices: Products that assist in occluding blood vessels during surgical procedures to manage blood flow.
- Embolic Protection Products: Devices that protect against embolisms during interventions and assist in maintaining blood flow to critical areas.

- Advanced Surgical: This division equips healthcare providers with necessary surgical tools and instruments, which include:
- Laparoscopic and Endoscopic Surgical Instrumentation: Specialized instruments used in minimally invasive surgeries.
- Disposable Biopsy Forceps: Tools designed for obtaining tissue samples during endoscopic procedures.
- Other Disposable Surgical Devices: A range of single-use surgical items that ensure sterility and minimize the risk of infection in surgical settings.

Non-Medical Segment
The Non-Medical Segment of Integer Holdings Corporation focuses on providing high-performance battery solutions and customized industrial technologies. This segment is vital for clients across various industries:

- Battery Division: This division is dedicated to the development of advanced battery solutions that are engineered for demanding environments and applications. Key offerings include:
- High-Performance Batteries: Suitable for applications in military and aerospace, offering reliability and durability in critical operations.
- Capacitors: Designed for energy storage and power management across a variety of devices, including medical equipment.

- Industrial Division: This division offers tailored solutions designed for diverse industrial applications, emphasizing quality and innovation. Services include:
- Machining and Fabrication: Providing customized manufacturing services to meet specific client requirements.
- Engineering Services: Collaborative development processes aimed at creating functionality-driven designs for industrial applications.
- Testing Services: Ensuring product performance and reliability through rigorous testing protocols that meet industry standards.

Overall Value Proposition
Integer Holdings Corporation is committed to enhancing the quality of life for patients through its innovative medical products and services while supporting industrial clients with customized, high-performance solutions. The companys focus on research, development, and production is driven by a commitment to quality, cost-effectiveness, and sustainability, making it a leader in both segments. Their emphasis on innovation ensures continuous improvement in technology and product offerings, aligning with the dynamic needs of the markets they serve.
Get the full CSIMarket dataset: Subscribe API License